
Exaia Technologies provides research-backed, explainable AI-powered solutions for natural language processing and machine learning applications, focusing on high-stakes domains like healthcare and finance. Their platform aims to enhance decision-making with trustworthy AI, particularly in precision medicine for neurodegenerative and psychiatric diseases using digital biomarkers. They offer advanced model architectures, comprehensive XAI insights, and products like Cymo (text mining) and Metis (predictive analytics). The company emphasizes scientific validation and has a strong research foundation with numerous peer-reviewed publications.

Exaia Technologies provides research-backed, explainable AI-powered solutions for natural language processing and machine learning applications, focusing on high-stakes domains like healthcare and finance. Their platform aims to enhance decision-making with trustworthy AI, particularly in precision medicine for neurodegenerative and psychiatric diseases using digital biomarkers. They offer advanced model architectures, comprehensive XAI insights, and products like Cymo (text mining) and Metis (predictive analytics). The company emphasizes scientific validation and has a strong research foundation with numerous peer-reviewed publications.